Quest for the right Drug
מסטינון מחפיות 60 מ"ג MESTINON DRAGEES 60 MG (PYRIDOSTIGMINE BROMIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
דרז'ה : DRAGEE
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Overdose : מינון יתר
4.9 Overdose An overdose of Mestinon dragees 60 mg can lead to a cholinergic crisis which necessitates intensive care monitoring. If a situation like this is not recognised, there is a risk of life- threatening respiratory muscle paralysis. Possible symptoms of a cholinergic crisis Muscarinic effects Hypersalivation, lacrimation, rhinorrhoea, light to heavy sweating, increased bronchial secretion, bronchospasm, skin redness, miosis and accommodation disorders, dizziness, nausea, vomiting, increased peristalsis and diarrhoea, involuntary micturition and defecation with abdominal cramps, extreme bradycardia to the point of cardiac arrest, a drop in blood pressure through to circulatory collapse, periodic sinus tachycardia, pulmonary oedema. Nicotinergic effects Occasional muscle cramps, fasciculations, adynamia, general weakness through to paralysis which can lead to apnoea and cerebral anoxia in particularly serious cases. Symptoms involving the central nervous system can be observed, including unrest, confusion, slurred speech, nervousness, irritability, and visual hallucinations. Convulsions and coma may occur. Treatment of a cholinergic crisis - Immediately discontinue acetylcholinesterase inhibitors. Stop medications for 3 to 4 days - Artificial respiration in the event of significant respiratory depression - Slow intravenous administration of atropine (1 to 2 mg atropine sulphate) (every 5 to 30 min. if necessary) and dose reduction according to clinical factors (particularly pulse rate) - No plasma therapy - In the case of heavy congestion: intensive respiratory toilet, i.v. fluids, secretolytics, broncholytics if necessary. - Careful resumption of acetylcholinesterase inhibitor therapy, e.g. start with 0.5 mg pyridostigmine bromide parenterally every 4 to 6 hours or 4 x 20 mg pyridostigmine bromide orally Treatment in the case of accommodation disorders Mydriatics, e.g. tropicamide (monitor pressure!).
שימוש לפי פנקס קופ''ח כללית 1994
Myasthenia gravis
תאריך הכללה מקורי בסל
01/01/1995
הגבלות
תרופה שאושרה לשימוש כללי בקופ'ח
מידע נוסף